Remarkable response to photodynamic therapy in residual T4N0M0 nasopharyngeal carcinoma: a case report

Photodiagnosis Photodyn Ther. 2012 Dec;9(4):319-20. doi: 10.1016/j.pdpdt.2012.06.005. Epub 2012 Aug 3.

Abstract

Local treatment of residual or recurrent nasopharyngeal carcinoma (NPC) is a challenge. Photodynamic therapy (PDT) is an established treatment modality for incurable head and neck carcinoma. Several studies reported induction of an immune response after PDT. We present a patient with residual T4N0M0 NPC who was treated with PDT for residual disease after initial treatment with neo-adjuvant chemotherapy and radiotherapy. Five years after PDT, the tumor did not progress and the patient is still in good condition. We discuss this remarkable long-term response to PDT and speculate on possible mechanisms.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Carcinoma
  • Humans
  • Male
  • Mesoporphyrins / therapeutic use*
  • Nasopharyngeal Carcinoma
  • Nasopharyngeal Neoplasms / drug therapy*
  • Neoadjuvant Therapy
  • Neoplasm, Residual / therapy
  • Photochemotherapy / methods*
  • Photosensitizing Agents / therapeutic use*

Substances

  • Mesoporphyrins
  • Photosensitizing Agents
  • temoporfin